The special issue provides a wealth of information on diabetes
prevention and control, based on the just-released results of a
binational research project conducted among the U.S.-Mexico border
population. The study was coordinated by the PAHO/WHO U.S.-Mexico Border
Office in El Paso, Texas, in a special partnership between Mexico’s
ministry of health (Secretaría de Salud) and the U.S. Centers for
Disease Control and Prevention, among other institutions.
Type 2 diabetes currently affects more than 220 million people globally. In Mexico, this disease is the leading cause of mortality, whereas in the United States, it ranks number three. Along the border between the two countries, diabetes-related morbidity and mortality rates were disproportionately high, with public health authorities on both sides calling for immediate action.
The findings of the U.S.-Mexico Border Diabetes Prevention and
Control Project validated the worst fears of local and national
decision-makers and confirm the urgent need for well-coordinated
cross-border efforts to translate the valuable knowledge gained into
effective strategies, policies, and plans to turn back the tide on this
no-longer-so-silent killer.
For more information please contact: Lorely Ambriz, M.S.I.S, Knowledge Management & Communication Advisor.
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
| Pan American Health Organization (PAHO) / A Regional Office of the World Health Organization (WHO) United States-Mexico Border Office: 5400 Suncrest Dr. Ste. C-4 El Paso, TX 79912. Office (915) 845-5950 Ext. 2523 / Cel (915) 449-3040 / Fax (915) 845-4361.